AC Immune SA (ACIU)
2.86
-0.07 (2.39%)
Upcoming Events
Latest Headlines
H.C. Wainwright Reiterates Buy Rating on AC Immune SA (ACIU)
August 24, 2026 6:55 AM - StreetInsider
Form 6-K AC Immune SA For: Aug 20
August 20, 2026 7:00 AM - SEC Filing
AC Immune reports early Phase 1 data for NLRP3 inhibitor ACI-19764
August 20, 2026 7:00 AM - StreetInsider
AC Immune Announces Positive Preliminary Phase 1 Data for NLRP3 Inhibitor ACI-19764
August 20, 2026 7:00 AM - StreetInsider
Form 6-K AC Immune SA For: Aug 11
August 11, 2026 7:00 AM - SEC Filing
AC Immune gets FDA fast track for Parkinson's drug ACI-7104
August 11, 2026 7:00 AM - StreetInsider
AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s Disease (PD)
August 11, 2026 7:00 AM - StreetInsider
Form 6-K AC Immune SA For: Jun 30
August 5, 2026 7:01 AM - SEC Filing
AC Immune First Half 2026 Financial and Corporate Update
August 5, 2026 7:00 AM - StreetInsider
AC Immune to Showcase Neurodegenerative Disease Pipeline with Three Presentations at AAIC® 2026
July 7, 2026 7:00 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on AC Immune SA (ACIU)
July 1, 2026 7:04 AM - StreetInsider
Form 6-K AC Immune SA For: Jun 30
June 30, 2026 9:04 AM - SEC Filing
AC Immune reports 12-month interim data from ACI-24 Alzheimer's trial
June 30, 2026 7:00 AM - StreetInsider
AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease
June 30, 2026 7:00 AM - StreetInsider
Form 4 AC Immune SA For: Jun 11 Filed by: Twyman Roy Ervin
June 15, 2026 7:10 AM - SEC Filing
Form 4 AC Immune SA For: Jun 11 Filed by: AGUIAR-LUCANDER RENEE
June 15, 2026 6:59 AM - SEC Filing
Form 4 AC Immune SA For: Jun 11 Filed by: Zuegel Martin
June 15, 2026 6:50 AM - SEC Filing
Form 4 AC Immune SA For: Jun 11 Filed by: Buetler Monika
June 15, 2026 6:40 AM - SEC Filing
Form 4 AC Immune SA For: Jun 11 Filed by: June Carl Howard
June 15, 2026 6:32 AM - SEC Filing
Form 6-K AC Immune SA For: Jun 11
June 11, 2026 4:54 PM - SEC Filing
Form 6-K AC Immune SA For: Jun 11
June 11, 2026 7:15 AM - SEC Filing
AC Immune receives $4 million grant for Parkinson's drug trial extension
June 11, 2026 7:00 AM - StreetInsider
AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson’s Disease
June 11, 2026 7:00 AM - StreetInsider
Full Article List